Frederick MacFadgen

Frederick MacFadgen is an experienced financial professional currently serving as FP&A Director at Xenon Pharmaceuticals Inc. since April 2024, after holding positions such as Associate Director of R&D Financial Planning & Analysis at the same company and Associate Director of FP&A, G&A, Corporate Consolidation at Moderna from June 2023 to January 2024. Previous experience includes Senior Manager of Clinical Financial Planning for R&D at Biogen and Business Planning & Finance Lead at Pfizer, where responsibilities encompassed managing budgets, overseeing financial operations, and preparing forecasts. Frederick also has an extensive background in project controls and financial analysis from roles at Pfizer and Wyeth Research, and holds a Bachelor's degree in Accounting and Finance from UMass Boston.